MediXall (MDXL) Income from Continuing Operations (2019 - 2024)
MediXall's Income from Continuing Operations history spans 8 years, with the latest figure at 263813.0 for Q3 2024.
- For Q3 2024, Income from Continuing Operations rose 129.05% year-over-year to 263813.0; the TTM value through Sep 2024 reached 2163115.0, up 55.78%, while the annual FY2023 figure was 4563406.0, 33.19% up from the prior year.
- Income from Continuing Operations reached 263813.0 in Q3 2024 per MDXL's latest filing, up from 485862.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 263813.0 in Q3 2024 to a low of 2410102.0 in Q1 2022.
- Average Income from Continuing Operations over 5 years is 1275530.32, with a median of 1332301.0 recorded in 2021.
- Peak YoY movement for Income from Continuing Operations: plummeted 80.9% in 2022, then skyrocketed 129.05% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 1968306.0 in 2020, then rose by 7.64% to 1817886.0 in 2021, then increased by 1.95% to 1782441.0 in 2022, then rose by 18.4% to 1454466.0 in 2023, then soared by 118.14% to 263813.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Income from Continuing Operations are 263813.0 (Q3 2024), 485862.0 (Q2 2024), and 486600.0 (Q1 2024).